SOLUBLE ST2 PREDICTS INCIDENT HEART FAILURE AND CARDIOVASCULAR DEATH IN OLDER ADULTS

被引：1
|
作者：
Ginsberg, Eric [1 ]
Seliger, Stephen [1 ]
Gottdiener, John [1 ]
Christenson, Robert [1 ]
End, Christopher [1 ]
DeFilippi, Christopher [1 ]
机构：
[1] Univ Maryland, Baltimore, MD 21201 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2014年 / 63卷 / 12期
关键词：
D O I：
10.1016/S0735-1097(14)60768-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1114-172
引用
收藏
页码：A768 / A768
页数：1
相关论文
共 50 条
  • [41] Soluble ST2 protein in chronic heart failure is independent of traditional factors
    Wojtczak-Soska, Karolina
    Pietrucha, Tadeusz
    Sakowicz, Agata
    Lelonek, Malgorzata
    ARCHIVES OF MEDICAL SCIENCE, 2013, 9 (01) : 21 - 26
  • [42] Galectin-3 and Soluble ST2 and Kidney Function Decline in Older Adults: The Cardiovascular Health Study (CHS)
    Bansal, Nisha
    Katz, Ronit
    Seliger, Stephen
    DeFilippi, Christopher
    Sarnak, Mark J.
    Delaney, Joseph A.
    Christenson, Robert
    de Boer, Ian H.
    Kestenbaum, Bryan
    Robinson-Cohen, Cassianne
    Ix, Joachim H.
    Shlipak, Michael G.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2016, 67 (06) : 994 - 996
  • [43] Soluble ST2 biomarker and reverse remodelling in patients with systolic heart failure
    Yalta, Kenan
    Zorkun, Cafer
    INDIAN HEART JOURNAL, 2018, 70 (01) : 196 - 196
  • [44] The Diagnostic Value of Soluble ST2 in Heart Failure: A Meta-Analysis
    Yang, Chaojun
    Fan, Zhixing
    Wu, Jinchun
    Zhang, Jing
    Zhang, Wei
    Yang, Jian
    Yang, Jun
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [45] Soluble ST2 proteins in male cachectic patients with chronic heart failure
    Sobieszek, Grzegorz
    Powrozek, Tomasz
    Jaroszynski, Andrzej
    Skwarek-Dziekanowska, Aneta
    Rahnama-Hezavah, Mansur
    Malecka-Massalska, Teresa
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2021, 31 (03) : 886 - 893
  • [46] Plasma Levels of ST2 in the Community: ST2 is Associated with Increased Risk of Incident Heart Failure and Mortality but not with Altered Ventricular Function
    AbouEzzeddine, Omar F.
    Kane, Garvan C.
    Rodeheffer, Richard J.
    Chen, Horng H.
    Saenger, Amy K.
    Scott, Christopher G.
    Felker, Michael
    Jaffe, Allan S.
    Burnett, John C.
    Redfield, Margaret M.
    CIRCULATION, 2012, 126 (21)
  • [47] Soluble ST2 to identify the risk of new-onset reduced versus preserved ejection fraction heart failure in community dwelling older adults
    Defilippi, C.
    Christenson, R.
    Gottdiener, J.
    Seliger, S.
    EUROPEAN HEART JOURNAL, 2014, 35 : 220 - 220
  • [48] Soluble ST2 for Predicting Sudden Cardiac Death in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction
    Pascual-Figal, Domingo A.
    Ordonez-Llanos, Jordi
    Tornel, Pedro L.
    Vazquez, Rafael
    Puig, Teresa
    Valdes, Mariano
    Cinca, Juan
    Bayes de Luna, Antoni
    Bayes-Genis, Antoni
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (23) : 2174 - 2179
  • [49] Circulating Soluble ST2 Predicts All-Cause Mortality in Severe Heart Failure Patients with an Implantable Cardioverter Defibrillator
    Hou, Zhi-wei
    Yu, Hai-bo
    Liang, Yan-chun
    Gao, Yang
    Xu, Guo-qing
    Wu, Min
    Mei, Zhu
    Wang, Zu-lu
    Li, Zhi-guo
    Li, Yu-ying
    Song, Hai-xu
    Li, Jia-yin
    Han, Ya-ling
    CARDIOLOGY RESEARCH AND PRACTICE, 2020, 2020
  • [50] Increased soluble ST2 is a stronger predictor of long-term cardiovascular death than natriuretic peptides in heart failure patients with reduced ejection fraction
    Gruson, Damien
    Lepoutre, Thibault
    Ahn, Sylvie A.
    Rousseau, Michel F.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 172 (01) : E250 - E252
12345